News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • CLINUVEL announces relocation of its corporate headquarters to the United States.
  • The company plans to reduce its global workforce by 10–20%.
  • CLINUVEL shifts its operational focus exclusively to the U.S. pharmaceutical market.
  • The move aims to improve access to U.S. investors and capital markets.
  • Restructuring is intended to better position CLINUVEL's late-stage pipeline, notably its vitiligo treatment, for U.S. commercialization.

Latest Articles

Bread Financial Announces Executive Leadership Changes

Bread Financial Announces Executive Leadership Changes

Bread Financial announced leadership changes in its commercial organization with Valerie Greer, EVP and Chief Commercial Officer, retiring after nearly 40 years in financial services. Dennis McCarthy will be promoted to EVP and Chief Revenue Officer, bringing extensive industry experience to guide the company’s next growth phase. Greer will remain …

Goldman Sees June Core CPI Slightly Below Consensus, Flags Policy Relevance

Goldman Sees June Core CPI Slightly Below Consensus, Flags Policy Relevance

Goldman Sachs projects June core consumer price index (CPI) to rise 0.17% month-over-month, a touch below market consensus, while headline CPI is expected to fall 0.11% month-over-month. The firm says the release will be an important input for Federal Reserve policy choices, with nuances across rent, travel, energy and autos shaping its softer core…

Macquarie Points to Hyatt as U.S. Hotel RevPAR Accelerates to 8.7% in June

Macquarie Points to Hyatt as U.S. Hotel RevPAR Accelerates to 8.7% in June

Preliminary data compiled by Macquarie shows U.S. revenue per available room (RevPAR) rose 8.7% in June 2026, driven by a mix of leisure travel and World Cup-related demand. The increase reflected gains in both average daily rate and occupancy, with luxury and upper-upscale hotels outperforming lower chainscales. Macquarie favors Hyatt Hotels based…

Mainframe weakness drags IBM shares as Q2 results miss expectations

Mainframe weakness drags IBM shares as Q2 results miss expectations

IBM reported second-quarter revenue and non-GAAP EPS below analyst consensus, citing softness in its Z mainframe transaction processing and a shift in client capital spending toward servers, storage and memory. Shares fell 14% on the news as the company detailed margin contractions, cash flow generation and pockets of growth in Red Hat and Distribu…

Cisco Has Room To Rerate: Buy On Tilted Odds, Not Blind Faith

Cisco Has Room To Rerate: Buy On Tilted Odds, Not Blind Faith

Cisco's shares have recovered from 2025 lows and are trading in the low $120s, but fundamentals and the AI/data-center driven networking cycle argue there is further upside if the market reassigns a higher multiple. The company's strong ROE, $11.8B in free cash flow, and modest leverage underpin a long trade. We lay out an entry at $119.60, stop at…

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Kura Oncology announced that updated results from its FIT-001 Phase 1a study evaluating darlifarnib plus cabozantinib in cabozantinib-naïve advanced clear cell renal cell carcinoma (ccRCC) patients will be presented orally at the 2026 Kidney Cancer Research Summit. These long-term follow-up data continue to support darlifarnib's potential to enhanc…

China Ousts Politburo Member Ma Xingrui in Expanded Anti-Corruption Campaign

China Ousts Politburo Member Ma Xingrui in Expanded Anti-Corruption Campaign

China has expelled Ma Xingrui, a former member of the Politburo and ex-deputy head of the central rural work leading group, from the Communist Party following an investigation that found he facilitated appointments, arranged jobs for associates and allowed family members to profit from his position. The Central Commission for Discipline Inspection …

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Can-Fite BioPharma announced the granting of an Australian patent application titled "Treatment of Advanced Metastatic Cancer," further protecting its oncology drug Namodenoson. The drug is currently in pivotal Phase 3 trial for hepatocellular carcinoma and has completed Phase 2a trial in pancreatic cancer with plans for a Phase 2b study in combina…

Octave to Report Second Quarter 2026 Financial Results on August 12

Octave to Report Second Quarter 2026 Financial Results on August 12

Octave Intelligence plc will report its second quarter 2026 financial results on August 12, 2026, before the U.S. market opens. The company will also hold a live conference call to discuss the results and business outlook. Octave provides software for mission-critical facilities and infrastructure, aiming to improve asset lifecycle performance and …